MGI and AddLife AB: A Strategic Collaboration to Revolutionize Life Science in the Nordic Region
Friday, June 9, 2023
Share
MGI and AddLife AB: A Strategic Collaboration to Revolutionize Life Science in the Nordic Region
Stockholm, Sweden, 8 June 2023 - MGI Tech Co. Ltd. ("MGI"), a global leader in life science technology, is thrilled to announce a strategic collaboration with AddLife AB, one of Europe's largest distributors of clinical testing and laboratory equipment. This partnership aims to significantly enhance the distribution of MGI's cutting-edge products* in the Nordic region, leveraging the expertise and market presence of AddLife AB's Triolab Group subsidiaries, and expanding into innovative fields such as point-of-care testing (POCT) and remote ultrasound.
The Power of Partnership: MGI and AddLife AB
Under the agreement, AddLife AB's four Triolab Group subsidiaries, namely Triolab Sweden, Triolab Norway, Triolab Denmark (Iceland), and Triolab Finland will serve as separate distributors for MGI's innovative products*. This partnership represents a significant milestone in the life science industry, combining the strengths of two industry leaders to meet the evolving needs of healthcare providers in the Nordic region.
A Shared Vision for Innovation and Excellence
"At AddLife, we aim to meet all our customers' needs at the highest level. Innovation is one of our core values and the addition of the product line from MGI is a perfect complement to our laboratory portfolio in that respect. It gives our customers the possibility to use the most modern and innovative technology.", Kai Rantanen, Head of the Diagnostic Business at AddLife AB said.
MGI's Commitment to Advancing Life Science
Duncan Yu, President of MGI, also shared his thoughts on the collaboration, stating, "We are thrilled to partner with AddLife AB and its Triolab Group subsidiaries to expand our reach in the Nordic region. The extensive distribution network and market expertise of AddLife AB, combined with MGI's leading-edge sequencing products*, will enable us to effectively meet the needs of healthcare professionals and contribute to improved patient outcomes.”
A Milestone in Healthcare Innovation
The collaboration between MGI and AddLife AB represents a significant milestone in responding to the evolving needs of healthcare providers in the Nordic region. By combining their respective strengths and expertise, both companies aim to accelerate the adoption of cutting-edge sequencing technologies and promote improved patient care across the region.
About AddLife
AddLife is an independent European provider in life science that offers high quality products, services and consulting to both the private and public sectors. AddLife has about 2,200 employees in around 85 operating subsidiaries, which operate under their own brands. The Group has annual sales of approximately SEK 9 billion. AddLife is listed on the Nasdaq Stockholm stock exchange.
About MGI
MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.
MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.
The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.
For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.
MGI TECH CO., LTD.
LIFE SCIENCE INNOVATION
ADDLIFE AB
GENE SEQUENCING
TRIOLAB GROUP
Share
More news
Jun 17, 2024
MGI Tech and SeqOne Partner to Advance End-to-end Genomic Analysis
MGI has announced a collaboration with SeqOne, a leading provider of AI-driven genomic decision support software, to develop and validate comprehensive genomic analysis solutions tailored to Human Genetics and Pathology labs worldwide.
Jun 3, 2024
MGI Tech Unveils New European Headquarters in Berlin, Germany
MGI opens its new European headquarters in Berlin, featuring advanced labs, a Customer Experience Center, and showcasing the latest life science innovations and multi-omics tools.
Jun 3, 2024
MGI Shares New Data on Core DNEBSEQ Technology and Showcases Latest Sequencing Innovations at ESHG 2024
MGI Tech unveils Q40 quality data for DNBSEQ with StandardMPS 2.0 Chemistry and launches DNBelab C-TaiM 4 Single-Cell Droplet Generator at ESHG 2024, showcasing major innovations.